June 22, 2021 JUNE 4, 2021 SARC SEMIANNUAL MEETING Thank you for attending the 2021 SARC Semiannual Virtual Meeting on June 4, 2021. If you were not able to join the virtual event please view the agenda along with … Read more
June 2, 2021 It’s not too late! REGISTER NOW: SARC Semiannual Meeting SARC Semiannual Virtual Meeting Friday, June 4, 20219:00 am–12:00 pm EDT Click REGISTER TODAY Registrants will receive a meeting link in advance of the virtual event. Read more
May 24, 2021 Understanding Adoptive Cell Therapy for Sarcoma Adoptive Cell Therapy is a type of cancer treatment that uses your own immune system to treat your cancer; it may be an option for patients with some types of … Read more
September 2, 2020 SARC ANNOUNCES THE APPOINTMENT OF NEW LEADERSHIP With the decision of Denise Reinke earlier this year to step down from her roles as president and CEO and board chair, SARC is pleased to announce the successful recruitment … Read more
April 28, 2020 Message from SARC President and CEO, Denise Reinke This year will mark a change for SARC, as I have decided to step down as President & CEO. I have been privileged to be a part of SARC from … Read more
February 28, 2019 RARE DISEASE DAY 2019 Rare Disease Day 2019 was marked on February 28 around the world and at the NIH with a special day filled with opportunities to meet wonderful people committed to making … Read more
January 18, 2019 LILLY REPORTS RESULTS OF PHASE 3 SOFT TISSUE SARCOMA Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue … Read more
June 28, 2018 SARC Investigator-Initiated Osteosarcoma Study Shows Positive Results of Regorafenib SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to report the positive results of their osteosarcoma trial of regorafenib. The goal of improving progression-free survival for patients receiving regorafenib … Read more
June 1, 2018 2018 CAREER DEVELOPMENT PROGRAM AWARD RECIPIENT ANNOUNCED CONGRATULATIONS ANUSHA KALBASI, MD SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to announce Dr. Anusha Kalbasi as the 2018 SARC Career Development Program Award recipient. At the 2018 … Read more
May 10, 2018 SARC009 PUBLISHED JAMA Oncology Publication of SARC Study of Dasatinib Under the leadership of Dr. Scott Schuetze, Professor at the Rogel Cancer Center, Michigan Medicine, the results of the collaborative trial of … Read more